Relative to its peers, NVO does not have very much institutional sponsorship. The 9.55% of shares outstanding held by institutional investors is among the least of any stock in the Pharmaceuticals: Major industry.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
COLUMBIA MANAGEMENT INVESTMENT A... Bought 1.8 Million shares of Novo Nordisk
ARROWSTREET CAPITAL LP Bought 1.1 Million shares of Novo Nordisk
FIDELITY MANAGEMENT & RESEARCH C... Bought 925.5 Thousand shares of Novo Nordisk